Given the observed role of HDACs in OAC tumorigenesis and the impact of HDACi on the TME in other cancers, targeted HDAC therapy in OAC may be successful in promoting an anti-tumour response within the OAC TME. This evidence concerns the gene HDAC9 and cancer.